Two Endogenous Antiangiogenic Inhibitors, Endostatin and Angiostatin, Demonstrate Biphasic Curves in their Antitumor Profiles
Angiogenesis refers to growth of blood vessels from pre-existing ones. In 1971, Folkman proposed that by choking off the blood supply to tumors, they are starved, leading to their demise. A few years ago, the monoclonal antibody Avastin became the first antiangiogenic biological approved by FDA, for...
Saved in:
Main Authors: | Kashi Javaherian (Author), Tong-Young Lee (Author), Robert M. Tjin Tham Sjin (Author), George E. Parris (Author), Lynn Hlatky (Author) |
---|---|
Format: | Book |
Published: |
SAGE Publishing,
2011-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Hypothesis Concerning the Biphasic Dose-response of Tumors to Angiostatin and Endostatin
by: George E. Parris
Published: (2015) -
Antiangiogenic and antitumor effects of Trypanosoma cruzi Calreticulin.
by: Nandy C López, et al.
Published: (2010) -
Diclofenac Loaded Biodegradable Nanoparticles as Antitumoral and Antiangiogenic Therapy
by: Gerard Esteruelas, et al.
Published: (2022) -
Endostatin Genetically Engineered Placental Mesenchymal Stromal Cells Carrying Doxorubicin-Loaded Mesoporous Silica Nanoparticles for Combined Chemo- and Antiangiogenic Therapy
by: Paz de la Torre, et al.
Published: (2021) -
Photodynamic therapy - hypericin tetraether liposome conjugates and their antitumor and antiangiogenic activity
by: Nikola Plenagl, et al.
Published: (2019)